Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2005
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288286 Anti-inflammatory medicaments
12/29/2005US20050288281 Hetero isonipecotic modulators of vanilloid VR1 receptor
12/29/2005US20050288273 Antibacterial agents
12/29/2005US20050288270 New aminopyridine derivatives and their use as pharmaceuticals
12/29/2005US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005DE102004028862A1 3-Aminoindazole 3 aminoindazoles
12/29/2005DE102004027358A1 Pyrimidinverbindungen und ihre Verwendung Pyrimidine compounds and their use
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005CA2570264A1 3-aminoindazoles
12/29/2005CA2570065A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609785A1 C-glycoside derivatives and salts thereof
12/28/2005EP1609362A2 Non-systemic control of parasites
12/28/2005EP1608662A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists
12/28/2005EP1608647A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors
12/28/2005EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608630A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
12/28/2005EP1608628A2 Histone deacetylase inhibitors
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608373A2 Tie-2 modulators and methods of use
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1461318B9 Tetrahydroquinoline analogues as muscarinic agonists
12/28/2005EP1432415B1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1234026C Electric filter for electronic display
12/27/2005US6979741 Acetyl-CoA carboxylase inhibitors
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979575 benzo[c,d]indolium derivative containing a quaternary ammonium or ammonium salt; used as fluorescent marker dye; a biomolecule labeled with the fluorescent marker dye
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/22/2005WO2005121136A1 Salt of phosphoric acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)-ethoxy] benzy] thiazolidin-2,4-dione and a method of its preparation
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121132A1 Fused heterocyclic compound having anti-hcv effect
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005120508A1 Benzothiazole antiviral agents
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005111031A3 Neuropeptide receptor modulators
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005WO2005082023A3 Heterocyclic self-immolative linkers and conjugates
12/22/2005WO2004082621A3 Novel ppar agonists, pharmaceutical compositions and uses thereof
12/22/2005US20050283005 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
12/22/2005US20050282875 Pyrrolidinium derivatives
12/22/2005US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
12/22/2005US20050282868 Substituted anthranilamides for controlling invertebrate pests
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282819 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia
12/22/2005US20050282818 Ubiquitin ligase inhibitors
12/22/2005US20050282815 Substituted N-(heteroar-beta-yl)aminopyridinecarboxamides or benzamides, e.g., 2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-N-(4-methylthiazol-2-yl)benzamide; glucokinase activators used to treat diabetes mellitus or obesity
12/22/2005US20050282807 Such as (S)-(4-(ethylamino)-2-((4-methylpiperidin-1-yl)methyl)thiazol-5-yl)(2-(methoxymethyl)pyrrolidin-1-yl)methanone; for treatment of neurological and psychiatric disorders/diseases, cancer, and disorders mediated by protein kinase inhibition
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282802 double salts of N-(3-Methyl-benzylidene)-N'-[6-morpholin-4-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine, having improved bioavailability, solubility, melting point and stability, used for the treatment of interleukin-12 (IL-12) related diseases or disorders
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/21/2005EP1607385A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
12/21/2005EP1606290A1 Weak base salts
12/21/2005EP1606289A1 Carboxamide derivatives
12/21/2005EP1606282A2 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
12/21/2005EP1606277A1 Imidazol-4-yl-ethynyl-pyridine derivatives
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/21/2005EP1606266A2 Chemical compounds
12/21/2005EP1606256A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1605946A2 Thiazoles useful as inhibitors of protein kinases
12/21/2005EP1605936A1 Aryl spirohydantoin cgrp receptor antagonists
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1173265B1 Sonic impinging jet crystallization apparatus and process
12/21/2005CN1711259A Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same
12/21/2005CN1711258A Pyrimidine compounds
12/20/2005US6977305 Modified carbocyanine dyes and their conjugates
12/20/2005US6977302 useful in treatment of fungal infections in humans and other mammals
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977252 Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs
1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 628